Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S‐mephenytoin oxidation in Tanzanians

dc.contributor.authorMutabingwa, Theonest K.
dc.date.accessioned2020-10-09T10:48:43Z
dc.date.available2020-10-09T10:48:43Z
dc.date.issued1996
dc.description.abstractS‐Mephenytoin and chloroguanide (proguanil) oxidation was studied in 216 Tanzanians. The mephenytoin S/R ratio in urine ranged from <0.1 to 1.16. The distribution was skewed to the right, without evidence of a bimodal distribution. Ten subjects (4.6%, 2.2% to 8.3%, 95% CI) with an S/R mephenytoin ratio >0.9, were arbitrarily defined as poor metabolizers of mephenytoin. The chloroguanide/cycloguanil ratio ranged from 0.82 to 249. There was a significant correlation between the mephenytoin S/R ratio and the chloroguanide/cycloguanil ratios (rs = 0.73; p < 0.00001). This indicates that cytochrome P4502C19 or CYP2C19 is a major enzyme that catalyzes the bioactivation of chloroguanide to cycloguanil. Chloroguanide is a pro‐drug, and hence a low CYP2C19 activity may lead to prophylactic failure caused by inadequate formation of cycloguanil. Fifty‐eight women who previously took either 200 mg chloroguanide daily (n = 26) or 200 mg chloroguanide daily plus 300 mg chloroquine weekly (n = 32) in a malaria chemoprophylaxis study showed that there was a significant correlation between the number of earlier breakthrough parasitemia episodes and the chloroguanide/cycloguanil ratio (rs = 0.30; p = 0.02). The breakthrough rate did not correlate with the S/R mephenytoin ratio. However, other factors, such as exposure to mosquitoes and sensitivity of the plasmodium to cycloguanil, are probably more important.en_US
dc.identifier.citationSkjelbo, E., Mutabingwa, T.K., Bygbjerg, I.B., Nielsen, K.K., Gram, L.F. and Brøsen, K., 1996. Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S‐mephenytoin oxidation in Tanzanians. Clinical Pharmacology & Therapeutics, 59(3), pp.304-311.en_US
dc.identifier.otherhttps://doi.org/10.1016/S0009-9236(96)80008-7
dc.identifier.urihttp://hdl.handle.net/123456789/631
dc.language.isoenen_US
dc.publisherClinical Pharmacology & Therapeuticsen_US
dc.subjectChloroguanide metabolismen_US
dc.subjectmalaria prophylaxis and the S‐mephenytoin oxidationen_US
dc.subjectTanzaniansen_US
dc.titleChloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S‐mephenytoin oxidation in Tanzaniansen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the.pdf
Size:
34.34 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections

Total Collections: 1